RECRUITING

A Setting Focus Overdose Prevention Intervention

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

A pilot injection-setting targeted peer-driven intervention to reduce HIV and hepatitis C virus transmission and overdose risk behaviors among people who inject drugs (PWID).

Official Title

A Geospatial Analysis of Hotspots and Targeted Injection Settings Pilot Intervention for HIV Prevention Among People Who Inject Drugs in Baltimore, Maryland

Quick Facts

Study Start:2022-04-30
Study Completion:2026-01-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05320835

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Current drug user (opioid use in the prior two weeks)
  1. * Any mental or physical health impairment that impedes ability to participate

Contacts and Locations

Study Contact

Carl Latkin, PhD
CONTACT
410-955-3972
carl.latkin@jhu.edu
Lauren Dayton, PhD
CONTACT
4105025368
ldayton2@jhu.edu

Principal Investigator

Carl Latkin, PhD
PRINCIPAL_INVESTIGATOR
Johns Hopkins Bloomberg School of Public Health

Study Locations (Sites)

Lighthouse Studies at Peer Point
Baltimore, Maryland, 21205
United States

Collaborators and Investigators

Sponsor: Johns Hopkins Bloomberg School of Public Health

  • Carl Latkin, PhD, PRINCIPAL_INVESTIGATOR, Johns Hopkins Bloomberg School of Public Health

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-04-30
Study Completion Date2026-01-31

Study Record Updates

Study Start Date2022-04-30
Study Completion Date2026-01-31

Terms related to this study

Additional Relevant MeSH Terms

  • HIV Infections
  • HCV
  • Drug Overdose